How can patients tell their Ozempic pen is empty
The evidence for GLP-1 therapy in lupus is limited
With all four core TRIUMPH trials now complete TRIUMPH-4 (December 2025, 28.7% weight loss), TRIUMPH-1 (May 2026, 28.3% in 2,339 patients), TRIUMPH-2 (July 2026, obesity + diabetes), and TRIUMPH-3 (July 2026, obesity + cardiovascular disease) plus TRANSCEND-T2D-1 (June 2026, the first diabetes-specific Phase 3 readout), this investigational medication now has the full data package Eli Lilly says it needs for regulatory submission
Beyond the temperature-cycling concern (refrigerator doors experience wider temperature swings than interior shelves), the door is exposed to room lighting every time the refrigerator is opened
When you come to Smart Skin, you can rest assured that every treatment our providers perform is safe